skip to content

RedWave Technology has successfully completed the sale of its business to 908 Devices (NASDAQ: MASS), a commercial-stage technology company that provides purpose-built handheld and desktop mass spectrometry devices.

RedWave Technologies Acquired By 908 Devices

Diamond Capital Advisors served as investment banker to RedWave by assisting in negotiations and acting as financial advisor. Diamond Capital Advisor’s deal team was led by Managing Director Michael Simon, and included Managing Director Shawn Thompson and Vice President Nicholas Berquist. This transaction will provide critical technology to 908 Technology and speed timeline to profitability.

About RedWave Technology

RedWave Technology, (“RedWave” or “the Company”), is a leading developer of portable, handheld Fourier Transform Infrared (FTIR) spectroscopy tools utilizing their cutting-edge technology for rapid detection and identification of various chemicals threats including gases and vapors, powders and liquids, and hazardous chemicals.

Based in Danbury, CT, RedWave has been at the forefront of innovation in portable FTIR chemical threat identification for emergency and military use. The Company is led by a team of engineering and business professionals that pioneered the development of portable FTIR spectroscopic analyzers that redefined chemical threat detection and identification. RedWave leverages their close working relationships with municipal departments, government agencies, and defense departments in the U.S. and beyond for deep insights into specialized needs. All products are designed to help these groups assess threats with greater ease, safety, and confidence.

About 908 Devices

908 Devices was founded in 2012 in Boston, MA. Since their inception, 908 Devices has developed several award-winning handheld and desktop mass spectroscopy devices. They have over 100 patents and sell their products in over 50 countries worldwide. Their products are designed to interrogate unknown and invisible materials in various fields including life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. 908 Devices seeks to revolutionize mass spectroscopy for chemical and biomolecular detection.

About Diamond Capital Advisors

Diamond Capital Advisors is a boutique middle-market investment banking firm located in Century City that performs a full range of investment banking services including mergers and acquisitions, valuations, and capital raises. See the Photonics section of our website for other relevant transactions.